FDA rejects widespread booster shots
An influential federal advisory panel has overwhelmingly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans. (Jae C. Hong/AP)
The decision is a huge step back from the sweeping plan proposed by the White House a month ago to offer booster shots of both the Pfizer and Moderna vaccines to nearly all Americans eight months after they get their second dose.
Reading comments and joining the conversation are some of the many benefits of subscribing. Join the conversation by clicking the View Comments button below. Not a subscriber? Click here.
Our commenting policy can be viewed here.